Larry Robbins's TEVA Position Overview
Larry Robbins (via Glenview Capital Management, LLC) currently holds 16.7M shares of Teva Pharmaceutical Industries Limited (TEVA) worth $337.19 M, representing 7.51% of the portfolio. First purchased in 2015-Q2, this long-term strategic position has been held for 42 quarters.
Based on 13F filings since 2013, Larry Robbins has maintained a long-term strategic position in TEVA, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2025, adding 6.3M shares. Largest reduction occurred in Q2 2016, reducing 2.5M shares.
Analysis based on 13F filings available since 2013 Q2
Larry Robbins's Teva Pharmaceutical Industries Limited (TEVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teva Pharmaceutical Industries Limited (TEVA) Trades by Larry Robbins
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2015 | +2.84 M | New Buy | 2.84 M | $59.10 |
| Q3 2015 | +1.34 M | Add 47.26% | 4.19 M | $56.46 |
| Q4 2015 | +1.77 M | Add 42.18% | 5.96 M | $65.64 |
| Q1 2016 | -376,484 | Reduce 6.32% | 5.58 M | $53.51 |
| Q2 2016 | -2.5 M | Reduce 44.75% | 3.08 M | $50.23 |
| Q3 2016 | -906,703 | Reduce 29.41% | 2.18 M | $46.01 |
| Q4 2016 | -2.18 M | Sold Out | 2.18 M | $0.00 |
| Q4 2023 | +1.6 M | New Buy | 1.6 M | $10.44 |
| Q1 2024 | +5.9 M | Add 367.48% | 7.5 M | $14.11 |
| Q2 2024 | +1.66 M | Add 22.08% | 9.16 M | $16.25 |
| Q3 2024 | -701,317 | Reduce 7.66% | 8.46 M | $18.02 |
| Q1 2025 | +6.32 M | Add 74.76% | 14.78 M | $15.37 |
| Q2 2025 | +1.05 M | Add 7.07% | 15.82 M | $16.76 |
| Q3 2025 | +868,457 | Add 5.49% | 16.69 M | $20.20 |
Larry Robbins's Teva Pharmaceutical Industries Limited Investment FAQs
Larry Robbins first purchased Teva Pharmaceutical Industries Limited (TEVA) in Q2 2015, acquiring 2,844,400 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins has held Teva Pharmaceutical Industries Limited (TEVA) for 42 quarters since Q2 2015. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins's largest addition to Teva Pharmaceutical Industries Limited (TEVA) was in Q1 2025, adding 14,778,641 shares worth $227.15 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Larry Robbins's firm, Glenview Capital Management, LLC, owns 16,692,680 shares of Teva Pharmaceutical Industries Limited (TEVA), valued at approximately $337.19 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Teva Pharmaceutical Industries Limited (TEVA) represents approximately 7.51% of Larry Robbins's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Larry Robbins's peak holding in Teva Pharmaceutical Industries Limited (TEVA) was 16,692,680 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.